Message #15 From:
Stock News Bot Date: December 27, 2006 10:35:00 AM
IOPM News IntraOp Medical Releases Fiscal 2006 Results
SUNNYVALE, Calif.--(BUSINESS WIRE)--IntraOp Medical Corporation (OTCBB:IOPM) issued record financial results
for its fiscal year ended September 30, 2006.
Donald A. Goer, Ph.D., President and CEO of IntraOp, stated, “In
the fourth quarter of FY2006 we shipped three Mobetron systems. The
revenue from these sales and our growing service operations resulted in
the best quarter in our history, and contributed to a record year for
sales, orders and backlog. We start FY2007 with a backlog of three
orders, and the continuing publication of positive clinical results on
intraoperative electron-beam radiation therapy is strengthening the
demand for Mobetron. We look to FY2007 to show still more significant
improvements in performance. We have added additional sales and service
staff, and feel confident that we will achieve our targets for the year.”
The Company recorded $5.98 million in sales for the year, with an
operating loss of $2.43 million and a net loss of $7.16 million. The
fourth quarter had sales of $3.67 million, with break even operations
and a net loss of $1.14 million.
About IntraOp
IntraOp Medical Corporation provides innovative technology solutions for
the treatment and eradication of cancer. Founded in 1993, IntraOp is
committed to providing the tools doctors need to administer
intraoperative electron-beam radiation therapy (IOERT) safely and
effectively – for all cancer patients. The
company’s flagship product, Mobetron, is the
first fully portable, self-shielding IOERT device designed for use in
any operating room. Key Mobetron benefits include: increased survival
rates, better local tumor control, shorter treatment cycles, and fewer
side effects. Leading hospitals, from university research centers to
specialized cancer clinics in North America, Europe and Asia, use
Mobetron as a vital part of their comprehensive cancer program.
For more information on IntraOp Medical Corporation, please visit www.intraopmedical.com.
Forward-Looking Statements
This press release may contain "forward-looking statements" within
the meaning of Section 27A of the 1933 Securities Act and Section 21E of
the 1934 Securities Exchange Act. Actual results could differ
materially, as the result of such factors as competition in the markets
for the company's products and services and the ability of the Company
to execute its plans. By making these forward-looking statements, the
Company can give no assurances that transactions described in this press
release will be successfully completed, and undertakes no obligation to
update these statements for revisions or changes after the date of this
press release.
